XYRA Announces Successful FDA End of Phase 2 Meeting and Agreement on Endpoints for Approval of Budiodarone for the Management of Atrial Fibrillation

XYRA United Kingdom England United States of America California

or [e-mail]

Photo - https://mma.prnewswire.com/media/2346660/Xyra.jpg
Logo -  https://mma.prnewswire.com/media/2346659/Xyra_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/xyra-announces-successful-fda-end-of-phase-2-meeting-and-agreement-on-endpoints-for-approval-of-budiodarone-for-the-management-of-atrial-fibrillation-302070508.html